Algo version: 0.98b
Johnson & Johnson is listed at the XETRA Exchange
Johnson & Johnson [JNJ.DE]
XETRA Sector: Pharmaceuticals Industry:Drug Manufacturers—General

Is Johnson & Johnson stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Johnson & Johnson pays dividends. Last time was Tuesday 10th of September 2024 where the investors holding the stock on Tuesday 27th of August 2024 were paid €1.24 per share. Over the last 69 times between 2008 and 2024, Johnson & Johnson has paid €61.035 with an average of €0.88 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Johnson & Johnson 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €114.58, you would have made a profit of €34.50 per share or 30.11%

No, the average daily trading liquidity for Johnson & Johnson is €3 162 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Johnson & Johnson has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.69, the company's ability to pay off the debt is good. Johnson & Johnson has a very good net profit margin of 42.91% and should have very high tolerances against inflation.

We have calculated the inflation risk for Johnson & Johnson to be low [0.15 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.